"LVH Hematology Oncology–1240 Cedar Crest is part of Lehigh Valley Topper Cancer Institute, a national leader in cancer care and a member of the Memorial Sloan Kettering Cancer Alliance. We care for individuals with cancer and blood-related diseases in a friendly, relaxed and confidential environment. We serve as patient advocates, working with our community partners to provide the best quality of life to those with cancer and their caregivers. Programs offered here include clinical trials, a variety of diagnostic, treatment and supportive care programs."

During the past decade, Lehigh Valley Physician Group (LVPG) - Hematology Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lehigh Valley Physician Group (LVPG) - Hematology Oncology" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lehigh Valley Physician Group (LVPG) - Hematology Oncology" are "Melanoma" (1 trials), "Melanoma (Skin)" (1 trials), "Melanoma Stage III" (1 trials), "Melanoma Stage IV" (1 trials) and "Metastatic Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Lehigh Valley Physician Group (LVPG) - Hematology Oncology" in a lesser frequency.

Most popular intervention types in "Lehigh Valley Physician Group (LVPG) - Hematology Oncology" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bempegaldesleukin" (1 trials), "Nivolumab" (1 trials), "bempegaldesleukin" (1 trials), "cabozantinib" (1 trials) and "nivolumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lehigh Valley Physician Group (LVPG) - Hematology Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lehigh Valley Physician Group (LVPG) - Hematology Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Lehigh Valley Physician Group (LVPG) - Hematology Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lehigh Valley Physician Group (LVPG) - Hematology Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".